Not sure anyone will get choked up about something or anything bad happening to Martin Shkreli or his smirk.
A federal judge ruled Monday that former drug company CEO Martin Shkreli will be held responsible for $10.4 million worth of financial losses related to his time as head of Turing Pharmaceuticals.
Judge Kiyo Matsumoto rejected Shkreli’s argument that he did not cause any losses for investors because they eventually came out with a profit, Reuters reported. The total losses will likely play a factor in Shkreli’s sentencing on March 9.
Matsumoto ruled Shkreli should not get credit for the money that was repaid to investors because he only returned it after they became suspicious.
(click here to continue reading Judge holds Martin Shkreli responsible for $10.4 million in losses | TheHill.)
Erin Lee Carr’s “Drug Short,” my candidate for a nonexistent Best in Show award, shows how big pharmaceutical companies jack up prices on lifesaving drugs, and how renegade short sellers with a pretense of social conscience get rich by trying to undermine companies they believe are spreading harm. The use of graphics in this one is particularly impressive; I’ve had short selling explained to me many times in the past, but I don’t think I ever really understood it on a fundamental level until Carr’s series laid it out.
(click here to continue reading Dirty Money Netflix Review.)